• Explore /
  • Poster
  • / Phase II study of neoadjuvant chemotherapy with modified FOLFOXIRI in borderline resectable or unresectable stage III pancreatic cancer.

Phase II study of neoadjuvant chemotherapy with modified FOLFOXIRI in borderline resectable or unresectable stage III pancreatic cancer.

Abstract Poster

Authors

null

Enrico Vasile

U.O. Oncologia Medica 2, Azienda Ospedaliero-Universitaria Pisana, Istituto Toscano Tumori, Pisa, Italy

Enrico Vasile , Nelide De Lio , Carla Cappelli , Luca Pollina , Niccola Funel , Aldo Sainato , Laura Ginocchi , Maurizio Lucchesi , Chiara Caparello , Sara Caponi , Vittorio Perrone , Francesco Pasqualetti , Fabio Caniglia , Stefano Signori , Salvatore Mazzeo , Carlo Greco , Alfredo Falcone , Daniela Campani , Franco Mosca , Ugo Boggi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Citation

J Clin Oncol 31, 2013 (suppl; abstr 4062)

DOI

10.1200/jco.2013.31.15_suppl.4062

Abstract #

4062

Poster Bd #

18H

Abstract Disclosures

Similar Posters

First Author: Choong-kun Lee

First Author: Veronica Conca

First Author: Charles D. Lopez

Poster

2022 ASCO Gastrointestinal Cancers Symposium

A phase II study of nivolumab in combination with modified FOLFIRINOX for metastatic pancreatic cancer.

A phase II study of nivolumab in combination with modified FOLFIRINOX for metastatic pancreatic cancer.

First Author: Makoto Ueno